Complex Regulatory Pathways Pose Hurdles For Effective CLs; Cipla’s Hamied Calls For Automatic Licensing Rights
This article was originally published in PharmAsia News
Executive Summary
Cipla Chairman Yusuf Hamied has proposed an automatic licensing mechanism that could avoid the need for a compulsory license and would allow generic firms to launch patented drugs via an automatic route.